The complexity of diagnosing adenosquamous carcinoma from core needle biopsies and the misidentification of poorly differentiated LUAD as LSCC are reported to underlie the tangible EGFR mutation rates reported in suspected LSCC biopsies (46, 49). The gene discussed is EGFR; the disease is adenosquamous carcinoma.